Results(4610)
Long-term effectiveness of cladribine in patients previously treated with oral cladribine: a Real-World Evidence analysis using data from the Italian Registry of Multiple Sclerosis (CLARINET-MS)
Italy
EU PAS number:
EUPAS25783
First published:
23/03/2026
Study
Finalised
id.DRIVE study of brand-specific respiratory syncytial virus (RSV) vaccine effectiveness in Europe
France
Germany
Italy
Spain
United Kingdom
EU PAS number:
EUPAS1000000035
First published:
23/03/2026
Study
Ongoing
id.DRIVE (former COVIDRIVE) study of brand-specific COVID-19 vaccine effectiveness against severe COVID-19 disease in Europe
France
Germany
Italy
Spain
United Kingdom
EU PAS number:
EUPAS42328
First published:
23/03/2026
Study
Ongoing
id.DRIVE surveillance study of respiratory pathogens in adults hospitalised for severe acute respiratory infection (SARI) across Europe
France
Germany
Italy
Spain
United Kingdom
EU PAS number:
EUPAS1000000012
First published:
23/03/2026
Study
Ongoing
COHORT STUDY ON THE SAFETY OF BIMEKIZUMAB IN PATIENTS WITH PLAQUE PSORIASIS, PSORIATIC ARTHRITIS, AXIAL SPONDYLOARTHRITIS, OR HIDRADENITIS SUPPURATIVA: A NON-INTERVENTIONAL POST AUTHORIZATION STUDY
France
United States
EU PAS number:
EUPAS1000000003
First published:
23/03/2026
Study
Ongoing
DARWIN EU® - Monitoring prescription of essential medicines administered in ICU
Finland
France
Greece
Hungary
Portugal
Spain
EU PAS number:
EUPAS1000000534
First published:
23/03/2026
Study
Finalised
DARWIN EU® - Capturing suicidality and depression related variables in databases
Denmark
Estonia
Finland
France
Germany
Greece
Netherlands
Norway
Portugal
Spain
Sweden
United Kingdom
EU PAS number:
EUPAS1000000825
First published:
23/03/2026
Study
Ongoing
DARWIN EU® - Use of antiretroviral therapies in paediatric patients
Germany
Norway
Spain
United Kingdom
EU PAS number:
EUPAS1000000545
First published:
23/03/2026
Study
Ongoing
Copenhagen Phase IV Unit (Phase4CPH), Center for Clinical Research and Prevention
Denmark
First published:
23/03/2026
Institution
Educational Institution
Hospital/Clinic/Other health care facility
ENCePP partner
The Danish Multiple Sclerosis Registry (DMSR), Rigshospitalet - Copenhagen University Hospital
Denmark
First published:
23/03/2026
Institution
Educational Institution
Hospital/Clinic/Other health care facility
Agenzia regionale di sanità della Toscana (ARS Toscana)
Italy
First published:
23/03/2026
Institution
EU Institution/Body/Agency
ENCePP partner
CAncer Risk and INsulin analoGues (CARING)
Denmark
Finland
Netherlands
Norway
Sweden
First published:
23/03/2026
Network
ENCePP partner
CAncer Risk and INsulin analoGues (CARING) project
Denmark
Finland
Netherlands
Norway
Sweden
EU PAS number:
EUPAS5383
First published:
20/03/2026
Study
Finalised
Post-authorisation safety study to evaluate the utilisation and safety of atogepant in patients with migraine and significant cardiovascular or cerebrovascular disease in Europe
Denmark
Netherlands
Spain
Sweden
EU PAS number:
EUPAS1000000648
First published:
20/03/2026
Study
Ongoing
REACH study: Real-World Evidence study of OM-85 in Adults and Children in China, Italy, and Belgium
Belgium
China
Italy
EU PAS number:
EUPAS1000000316
First published:
20/03/2026
Study
Planned
A Post-authorization Safety Study to Evaluate the Incidence of and Risk Factors for Severe and Fatal Infusion-related Reactions in Participants Treated with Daratumumab (Intravenous or Subcutaneous) (HALO)
Brazil
Canada
Czechia
France
Germany
Italy
Netherlands
Poland
Spain
United Kingdom
United States
EU PAS number:
EUPAS49827
First published:
20/03/2026
Study
Ongoing
A Nationwide Post-Marketing Study on the Safety of Abatacept Treatment in Denmark Using the DANBIO Register
Denmark
EU PAS number:
EUPAS31532
First published:
20/03/2026
Study
Finalised
A Nationwide Post-Marketing Study on the Safety of Abatacept Treatment in Sweden Using the SRQ Register
Sweden
EU PAS number:
EUPAS31529
First published:
20/03/2026
Study
Finalised
COVID-19 International Drug Pregnancy Registry (COVID-PR)
Australia
Canada
Denmark
Germany
Italy
Japan
Singapore
United Kingdom
United States
EU PAS number:
EUPAS42517
First published:
20/03/2026
Study
Ongoing
Interdisciplinary Outpatient Multimodal Pain Treatment After Non-Confirmation of Surgical Indication for Persistent Spinal Pain: Real-World Outcomes in 9,217 Patients (RESPONSE Study)
Germany
EU PAS number:
EUPAS1000000952
First published:
20/03/2026
Study
Finalised
Pediatric Oncology and Hematology Registry "Hope for children"
First published:
19/03/2026
Poland
Data source
Human
Cancer registryRecord completeness: 91%
WINE Study: Roxadustat Treatment of Anemia of Chronic Kidney Disease (CKD) in Real-world Clinical Practice - Observational Study Utilizing Routinely Collected Secondary Data from WiNe Registry in Germany
Germany
EU PAS number:
EUPAS1000000121
First published:
19/03/2026
Study
Finalised
Retrospective cohort study to assess the increased risk of myelotoxicity due to the combined use of fluoropyrimidines and thiazides
Spain
EU PAS number:
EUPAS1000000181
First published:
19/03/2026
Study
Finalised
Long-term outcomes in patients treated with ADVAGRAF following standard criteria donor or expanded criteria donor kidney transplant in routine clinical practice in Europe: a multicenter secondary data (chart review) cohort study
France
Germany
Spain
EU PAS number:
EUPAS1000000589
First published:
19/03/2026
Study
Ongoing
Long-term outcomes in patients continuously treated with ADVAGRAF following a liver transplant in routine clinical practice in Spain: a multicenter secondary data (chart review) cohort study
Spain
EU PAS number:
EUPAS1000000603
First published:
19/03/2026
Study
Ongoing
A standing cohort to understand the characteristics of patients with COVID-19 and contextualize the COVID-19 complication and safety events of interests using US OPTUM EHR data
United States
EU PAS number:
EUPAS48654
First published:
19/03/2026
Study
Finalised
DARWIN EU® - RR Childhood hypertension and sartans prescribing in children
Croatia
Denmark
Finland
France
Germany
Hungary
Netherlands
Norway
Spain
EU PAS number:
EUPAS1000000714
First published:
19/03/2026
Study
Finalised
Portal da Atrofia Muscular Espinhal (Spinal Muscular Atrophy Portal)
First published:
18/03/2026
Portugal
Data source
Human
Disease registry
Drug registryRecord completeness: 54%
MS-Register of the National MS-Society of Germany (DMSG, Bundesverband e.V.)
First published:
18/03/2026
Germany
Data source
Human
Disease registry
Primary care medical records
Spontaneous reports of suspected adverse drug reactionsRecord completeness: 97%
Hospital Universitario Virgen Macarena EHR
First published:
18/03/2026
Spain
Data source
Human
Emergency care discharge records
Hospital outpatient visit records
OtherRecord completeness: 82%
Portal da Hepatite C (Hepatitis C Portal)
First published:
18/03/2026
Portugal
Data source
Human
Disease registryRecord completeness: 35%
Non-interventional (observational) post-licensure study to assess the effectiveness and safety of recombinant zoster vaccine in adults aged =18 years with psoriasis or psoriatic arthritis (EPI-ZOSTER-045 VE US 216976)
United States
EU PAS number:
EUPAS107230
First published:
18/03/2026
Study
Ongoing
Cross-sectional study to assess the effectiveness of the patients’ alert card to inform on the risk of differentiation syndrome in AML patients treated with TIBSOVO® (Ivosidenib) (IMPACTA)
Austria
Belgium
France
Germany
Greece
Poland
EU PAS number:
EUPAS1000000190
First published:
18/03/2026
Study
Ongoing
Safety and effectiveness of RZV in adults ≥18 years of age with Systemic lupus erythematosus (SLE) or Multiple sclerosis (MS) (EPI-ZOSTER-041 VS US DB 215104)
United States
EU PAS number:
EUPAS107073
First published:
18/03/2026
Study
Ongoing
Oral and Long-Acting Injectable Cabotegravir Preexposure Prophylaxis Use Among U.S. Veterans Using Veterans Health Administration Services, 2021-2025 (306339)
United States
EU PAS number:
EUPAS1000000939
First published:
18/03/2026
Study
Ongoing
Impact of biologics on inhaled corticosteroids reduction (MOON LIGHT)
Argentina
Belgium
Brazil
Bulgaria
Canada
Colombia
Denmark
Estonia
France
Greece
India
Ireland
Italy
Japan
Korea, Republic of
Kuwait
Mexico
Norway
Poland
Portugal
Saudi Arabia
Singapore
Spain
Taiwan
United Arab Emirates
United Kingdom
United States
EU PAS number:
EUPAS1000000855
First published:
18/03/2026
Study
Ongoing
Sustainability of response to biologics in severe asthma and predictors of late failure among patients in an international registry (SHINE)
Argentina
Belgium
Brazil
Bulgaria
Canada
Colombia
Denmark
Estonia
Greece
Ireland
Italy
Japan
Korea, Republic of
Kuwait
Mexico
Norway
Poland
Portugal
Saudi Arabia
Singapore
Spain
Taiwan
United Arab Emirates
United Kingdom
United States
EU PAS number:
EUPAS1000000788
First published:
18/03/2026
Study
Ongoing
Real-life Enfortumab Vedotin Outcomes as First-line Urothelial Carcinoma Treatment in the Non-interventional Observational and Nationwide French Study
France
EU PAS number:
EUPAS1000000763
First published:
18/03/2026
Study
Planned
DARWIN EU® – Proof-of-concept: Preparedness for annual seasonal influenza vaccine effectiveness studies - Vaccine coverage and incidence of influenza-related outcomes
Croatia
Denmark
Finland
Norway
Spain
United Kingdom
EU PAS number:
EUPAS1000000803
First published:
18/03/2026
Study
Finalised
Avelumab in real-world treatment of urothelial cancer – The AVENUE NIS
Germany
Russian Federation
Spain
Switzerland
EU PAS number:
EUPAS42413
First published:
18/03/2026
Study
Ongoing
Compare data sources